Ceprotin

Ceprotin is a medicine used in patients with severe congenital protein C deficiency, a condition that increases the risk of blood clots. It is used to treat and prevent: - purpura fulminans (extensive clotting of blood within the blood vessels, which causes the death of the tissues just beneath the skin, often leading to organ failure and amputations); - coumarin-induced skin necrosis (a complication of medicines used to prevent blood clotting such as warfarin, which causes skin death); - venous thromboembolism (problems due to the formation of blood clots in the veins). Ceprotin contains the active substance human protein C.